Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes - Results from the 11-year follow-up of the Paris Prospective Study

Diabetologia

Volumn 32, Issue 5, 1989, Pages 300-304

  Fontbonne, A ^a   Eschwege E ^a   Cambien, F ^a   Richard, J L ^a   Ducimetiere P ^a   Thibult, N ^a   Warnet, J M ^b   Claude, J R ^b   Rosselin, G E ^a  

^a INSERM   (France)

^b INSERM Unité 258 ^*  (France)

Author keywords

coronary heart disease mortality; diabetes; Epidemiology; impaired glucose tolerance; plasma insulin level; plasma triglyceride level; risk factors

Indexed keywords

ADULT; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; CORONARY DISEASE; DIABETES MELLITUS; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN; PREDIABETIC STATE; REFERENCE VALUES; RISK FACTORS; SMOKING; SUPPORT, NON-U.S. GOV'T; TRIGLYCERIDES;

EID: 0024333622     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00265546     Document Type: Article

References (51)

1. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study
2. Absence of correlation between coronary arterial atherosclerosis and severity or duration of diabetes mellitus of adult onset
3. Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease — putative association via common antecedents; further evidence from the Whitehall Study
4. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland
5. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations
6. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population
7. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study ten years later
8. Pathogenesis of macrovascular disease including the influence of lipids
9. Plasma lipids and diabetes mellitus in an adult community
10. Lipid metabolism in diabetes mellitus
11. Plasma insulin and lipoprotein concentrations: an atherogenic association?
12. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride
13. Body mass, blood pressure, glucose and lipids. Does plasma insulin explain their relationships?
14. Beta-cell deficiency, insulin resistance, or both?
15. Separation of antibody bound and unbound peptide hormone labelled with iodine 131 by talcum powder and precipitates silica
16. Une méthode simple du dosage du cholestérol par voie automatique
17. Considérations pratiques sur le dosage semi-automatique des triglycérides sériques par fluorométrie (méthode de Kiessler et Lederer). Comparaison avec la méthode manuelle colorimétrique de Van Handel et Zilversmit
18. Regression models and life tables (with discussion)
19. Asymptomatic hyperglycaemia and coronary heart disease. A series of papers by the International Collaborative Group based on studies in fifteen populations. Joint discussion
20. A new concept of impaired glucose tolerance: relation to cardiovascular risk
21. Five-year incidence of major macrovascular complications in diabetes mellitus
22. The role of circulating glucose and triglyceride concentrations and their interaction with other risk factors as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study
23. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease
24. The triglyceride issue: a view from Framingham
25. Is the level of serum triglyceride a significant predictor of coronary death in “normocholesterolemic” subjects? The Paris Prospective Study
26. Metabolic and endocrine control of plasma high density lipoprotein concentration. Relation to catabolism of triglyceride-rich lipoproteins
27. Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population
28. High density lipoprotein as a protective factor against coronary heart disease
29. Metabolism of cholesterol and plasma triglycerides in non-ketotic diabetes mellitus
30. Serum lipids and lipoproteins in newly-diagnosed non-insulin-dependent (Type II) diabetic patients with special reference to factors influencing HDL-cholesterol and triglyceride levels
31. Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications
32. Insulin and HDL cholesterol metabolism
33. Hepatic insulin responsiveness in patients with endogenous hypertriglyceridaemia
34. Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men
35. Plasma insulin, serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects
36. Role of insulin in regulation of lipoprotein metabolism in diabetes
37. Very low density lipoproteins promote triglyceride accumulation in macrophages
38. Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential
39. Diabetes hypertriglyceridemia. Evidence for three clinical syndromes
40. Role of insulin resistance in human disease
41. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus
42. Very low density lipoproteins in Type II diabetes mellitus and risk of atherosclerosis
43. Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus
44. Relation of habitual diet to fasting plasma insulin concentration and the insulin response to oral glucose
45. Increased insulin receptors after exercise in patients with insulin dependent diabetes mellitus
46. Habitual physical activity and high density lipoprotein in men with primary hypercholesterolemia. The Lipid Research Clinic Coronary Primary Prevention Trial
47. Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus